Mill City Ventures III, Ltd.
Mill City Ventures III, Ltd. (MCVT) Financial Performance & Income Statement Overview
Analyze Mill City Ventures III, Ltd. (MCVT) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Mill City Ventures III, Ltd. (MCVT) Income Statement & Financial Overview
Analyze Mill City Ventures III, Ltd.’s MCVT earnings with segmented quarterly and yearly financial statement figures.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $940529.00 | $787202.00 | $711022.00 | $888629.00 |
Cost of Revenue | $16561.00 | $308418.00 | $11126.00 | $9545.00 |
Gross Profit | $940529.00 | $478784.00 | $1.009M | $945733.00 |
Gross Profit Ratio | $1.00 | $0.61 | $1.42 | $1.06 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $199953.00 | $289945.00 | $260649.00 | $242655.00 |
Operating Expenses | $379783.00 | $796882.00 | $408721.00 | $398059.00 |
Total Costs & Expenses | $379783.00 | $796882.00 | $419847.00 | $398059.00 |
Interest Income | $778027.00 | $868801.00 | $711022.00 | $888629.00 |
Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
Depreciation & Amortization | -$398000.00 | -$71919.00 | -$291000.00 | -$491000.00 |
EBITDA | $560746.00 | -$91607.00 | $291175.00 | $57104.00 |
EBITDA Ratio | $0.60 | -$0.12 | $0.41 | $0.06 |
Operating Income | $560746.00 | -$91607.00 | $291175.00 | $490570.00 |
Operating Income Ratio | $0.60 | -$0.12 | $0.41 | $0.55 |
Other Income/Expenses (Net) | $162502.00 | -$164000.00 | $298108.00 | $57104.00 |
Income Before Tax | $560746.00 | -$91607.00 | $589283.00 | $547674.00 |
Income Before Tax Ratio | $0.60 | -$0.12 | $0.83 | $0.62 |
Income Tax Expense | $109000.00 | -$511.00 | $125500.00 | $134738.00 |
Net Income | $451746.00 | -$91096.00 | $463783.00 | $412936.00 |
Net Income Ratio | $0.48 | -$0.12 | $0.65 | $0.46 |
EPS | $0.07 | -$0.01 | $0.07 | $0.06 |
Diluted EPS | $0.07 | -$0.01 | $0.07 | $0.06 |
Weighted Avg Shares Outstanding | $6.32M | $6.38M | $6.38M | $6.38M |
Weighted Avg Shares Outstanding (Diluted) | $6.37M | $6.49M | $6.50M | $6.50M |
The company's financials show resilient growth, with revenue advancing from $888629.00 in Q2 2024 to $940529.00 in Q1 2025. Gross profit remained healthy with margins at 100% in Q1 2025 compared to 106% in Q2 2024. Operating income hit $560746.00 last quarter, sustaining a consistent 60% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $560746.00. Net income rose to $451746.00, while earnings per share reached $0.07. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan